Concepedia

Eva Bondesson

EB

Statistics

Publications

18

Citations

773

H-Index

14

Active since

1994

Affiliations

AstraZeneca (Sweden)(Current)

Lund University

Sahlgrenska University Hospital

AstraZeneca (United Kingdom)

Malmö University

Eva Bondesson is an author at AstraZeneca (Sweden) specializing in pharmacy, pharmacology, and lung deposition.

Publications per year

1994–2018

18

Publications

18

Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects

Lars Borgström, Eva Bondesson, Folke Morén et al. · European Respiratory Journal · 1994 · 287 citations · Full text

, , +16

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

Andrew J. Armstrong, Aseem Anand, Lars Edenbrandt et al. · JAMA Oncology · 2018 · 102 citations · Full text

, , +17

Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction

CG Lofdahl, L. Andersson, Eva Bondesson et al. · European Respiratory Journal · 1997 · 52 citations · Full text

, , +17

Cumulative and Single-dose Design to Assess the Bronchodilator Effects of β2-Agonists in Individuals with Asthma

David Fishwick, Lisa Bradshaw, Claire Macdonald et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 40 citations

, , +17

Anti-Inflammatory Effects of Combined Budesonide/Formoterol in COPD Exacerbations

Erik Bathoorn, Jeroen J.W. Liesker, Dirkje S. Postma et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2008 · 36 citations

, , +17

1–5 of 18